Enanta Pharmaceuticals To Present Data For Zelicapavir, Oral, Once-Daily, N-Protein Inhibitor In Development For Treatment Of Respiratory Syncytial Virus At IDWeek 2026

뉴스 본문을 불러오고 있어요.

Enanta Pharmaceuticals To Present Data For Zelicapavir, Oral, Once-Daily, N-Protein Inhibitor In Development For Treatment Of Respiratory Syncytial Virus At IDWeek 2026 | 웨이프 WAPE

Enanta Pharmaceuticals To Present Data For Zelicapavir, Oral, Once-Daily, N-Protein Inhibitor In Development For Treatment Of Respiratory Syncytial Virus At IDWeek 2026

기사 요약

관련 종목

웨이프 AI가 분석했어요.

Enanta Pharmaceuticals가 IDWeek 2026에서 Zelicapavir 임상 데이터를 발표할 예정임.

댓글 —